日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy, Safety, and Biomarkers of Neoadjuvant Dalpiciclib (CDK4/6 inhibitor) plus Aromatase Inhibitors in Operable HER2-Negative Luminal B Breast Cancer: A Prospective, Single-Center, Single-Arm, Phase II Trial (DANCER)

新辅助达匹西利(CDK4/6 抑制剂)联合芳香化酶抑制剂治疗可手术 HER2 阴性 Luminal B 型乳腺癌的疗效、安全性和生物标志物:一项前瞻性、单中心、单臂 II 期试验 (DANCER)

Zhou, Yunxiang; Zhang, Zhiyun; Chen, Huihui; Huang, Fengbo; Shen, Lu; Tao, Siqi; Qian, Wei; Hong, Hui; Pan, Chi; Wang, Ze; Zhang, Jiao; Hu, Yue; Shen, Yong; Fu, Jun; Mao, Weikang; Wu, Shijie; Guo, Xianan; Wang, Hui; Ma, Mindi; Ma, Ting; Pan, Liqiang; Chen, Yiding

OmicStudio: A composable bioinformatics cloud platform with real-time feedback that can generate high-quality graphs for publication

OmicStudio:一个可组合的生物信息学云平台,具有实时反馈功能,能够生成高质量的用于发表的图表。

Lyu, Fengye; Han, Feiran; Ge, Changli; Mao, Weikang; Chen, Li; Hu, Huipeng; Chen, Guoguo; Lang, Qiulei; Fang, Chao

Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients.

识别与 COVID-19 患者无症状感染、疾病严重程度和病毒持续存在相关的不同免疫细胞亚群

Wang Xiaorui, Bai Han, Ma Junpeng, Qin Hongyu, Zeng Qiqi, Hu Fang, Jiang Tingting, Mao Weikang, Zhao Yang, Chen Xiaobei, Qi Xin, Li Mengyang, Xu Jiao, Hao Jingcan, Wang Yankui, Ding Xi, Liu Yuanrui, Huang Tianlong, Fang Chao, Ge Changli, Li Dong, Hu Ke, Ren Xianwen, Zhang Baojun, Zhang Binghong, Shi Bingyin, Zhang Chengsheng

Novel skewed usage of B-cell receptors in COVID-19 patients with various clinical presentations

COVID-19 患者中 B 细胞受体的新型偏倚使用及其与临床表现的关系

Ma, Junpeng; Bai, Han; Gong, Tian; Mao, Weikang; Nie, Yijun; Zhang, Xuan; Da, Yanyan; Wang, Xiaorui; Qin, Hongyu; Zeng, Qiqi; Hu, Fang; Qi, Xin; Shi, Bingyin; Zhang, Chengsheng

Identification of TCR repertoires in asymptomatic COVID-19 patients by single-cell T-cell receptor sequencing.

通过单细胞 T 细胞受体测序鉴定无症状 COVID-19 患者的 TCR 库

Bai Han, Ma Junpeng, Mao Weikang, Zhang Xuan, Nie Yijun, Hao Jingcan, Wang Xiaorui, Qin Hongyu, Zeng Qiqi, Hu Fang, Qi Xin, Chen Xiaobei, Li Dong, Zhang Binghong, Shi Bingyin, Zhang Chengsheng